Month: May 2022

AUM Biosciences Announces Clinical Trial Collaboration and Supply Agreement with MSD to Evaluate AUM001 in Combination with KEYTRUDA® (pembrolizumab) in Colorectal Cancer

Plan to conduct a global Phase 2 clinical trial to evaluate MNK inhibitor (AUM001) in combination with MSD’s anti-PD-1 therapy...

Pharnext: The Latest Findings From CMT&Me, a ‘Real-World’ Digital Lifestyle Study on Charcot-Marie-Tooth Diseases (‘CMTs’), to be Presented at the 2022 Peripheral Nerve Society (‘PNS’) Annual Meeting

error: Content is protected !!